Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G A Hofmann

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Journal of Natural Products|December 3, 1998
Isolation and structure elucidation of new PKCalpha inhibitors from Pinus flexilisK K Lee, B D Bahler, G A Hofmann, et al.
Cancer Research|May 15, 1990
Differences between normal and ras-transformed NIH-3T3 cells in expression of the 170kD and 180kD forms of topoisomerase IIR D Woessner, T D Chung, G A Hofmann, et al.
Journal of Natural Products|March 26, 1998
Limonoids showing selective toxicity to DNA repair-deficient yeast and other constituents of Trichilia emeticaA A Gunatilaka, V da S Bolzani, E Dagne, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2000
Highly efficient electro-gene therapy of solid tumor by using an expression plasmid for the herpes simplex virus thymidine kinase geneT Goto, T Nishi, T Tamura, et al.
Molecular Pharmacology|October 1, 1990
Development of a stable camptothecin-resistant subline of P388 leukemia with reduced topoisomerase I contentW K Eng, F L McCabe, K B Tan, et al.
Cancer Research|May 15, 1989
In vitro and intracellular inhibition of topoisomerase II by the antitumor agent merbaroneF H Drake, G A Hofmann, S M Mong, et al.
Journal of Natural Products|November 1, 1994
Protein kinase C inhibitors: novel spirosesquiterpene aldehydes from a marine sponge Aka (= Siphonodictyon) coralliphagumJ A Chan, A J Freyer, B K Carté, et al.
Oncology Research|January 1, 1992
Camptothecin hyper-resistant P388 cells: drug-dependent reduction in topoisomerase I contentR D Woessner, W K Eng, G A Hofmann, et al.
International Journal of Oncology|April 14, 2000
Gene delivery with optimized electroporation parameters shows potential for treatment of gliomasK Yoshizato, T Nishi, T Goto, et al.
Anti-Cancer Drug Design|August 1, 1989
Evidence for the participation of topoisomerases I and II in cadmium-induced metallothionein expression in Chinese hamster ovary cellsM R Mattern, K B Tan, J P Zimmerman, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Journal of Natural Products|December 3, 1998
Isolation and structure elucidation of new PKCalpha inhibitors from Pinus flexilisK K Lee, B D Bahler, G A Hofmann, et al.
Cancer Research|May 15, 1990
Differences between normal and ras-transformed NIH-3T3 cells in expression of the 170kD and 180kD forms of topoisomerase IIR D Woessner, T D Chung, G A Hofmann, et al.
Journal of Natural Products|March 26, 1998
Limonoids showing selective toxicity to DNA repair-deficient yeast and other constituents of Trichilia emeticaA A Gunatilaka, V da S Bolzani, E Dagne, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2000
Highly efficient electro-gene therapy of solid tumor by using an expression plasmid for the herpes simplex virus thymidine kinase geneT Goto, T Nishi, T Tamura, et al.
Molecular Pharmacology|October 1, 1990
Development of a stable camptothecin-resistant subline of P388 leukemia with reduced topoisomerase I contentW K Eng, F L McCabe, K B Tan, et al.
Cancer Research|May 15, 1989
In vitro and intracellular inhibition of topoisomerase II by the antitumor agent merbaroneF H Drake, G A Hofmann, S M Mong, et al.
Journal of Natural Products|November 1, 1994
Protein kinase C inhibitors: novel spirosesquiterpene aldehydes from a marine sponge Aka (= Siphonodictyon) coralliphagumJ A Chan, A J Freyer, B K Carté, et al.
Oncology Research|January 1, 1992
Camptothecin hyper-resistant P388 cells: drug-dependent reduction in topoisomerase I contentR D Woessner, W K Eng, G A Hofmann, et al.
International Journal of Oncology|April 14, 2000
Gene delivery with optimized electroporation parameters shows potential for treatment of gliomasK Yoshizato, T Nishi, T Goto, et al.
Anti-Cancer Drug Design|August 1, 1989
Evidence for the participation of topoisomerases I and II in cadmium-induced metallothionein expression in Chinese hamster ovary cellsM R Mattern, K B Tan, J P Zimmerman, et al.
Pageof 5